It is our pleasure to share with you that Rev1 portfolio company, Celenex, has been acquired by Amicus Therapeutics. Celenex licensed technology from Nationwide Children’s Hospital and The Ohio State… Read more
A discussion with Muyang Hu, Rev1 Director of Venture Acceleration What if your startup could attract $1MM or more in capital without giving up equity or creating debt? An opportunity… Read more
In a conversation with Rev1, Dr. Angel talks about how Anexsis is building a product with the features that customers want and will buy.
Last night’s VentureOhio VentureDinner was an exciting conclusion to a day packed with events in celebration of Ohio’s startup and investment community. VentureOhio announced winners in three categories of entrepreneurial… Read more